| Identification | Back Directory | [Name]
Fmoc-N-Me-Arg(pbf)-OH | [CAS]
913733-27-4 | [Synonyms]
FMOC-MEARG(PBF)-OH
Fmoc-N-Me-Arg(pbf)-OH
Fmoc-N-Me-L-Arg(Pbf)-OH
Fmoc-N-Me-Arg(pbf)-OH USP/EP/BP
Fmoc-N-Me-Arg(pbf)-OH 913733-27-4
NA-FMOC-NA-METHYL-NW-PBF-L-ARGININE
(9H-Fluoren-9-yl)MethOxy]Carbonyl N-Me-Arg(pbf)-OH
Nα-Fmoc-Nα-methyl-Nω-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sufonyl)-L-arginine
Nα-Fmoc-Nα-methyl-Nω-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sufonyl)-L-arginine≥ 99% (HPLC)
N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N2-methyl-L-ornithine
L-Ornithine, N5-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N2-methyl-
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanoic acid
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-5-{N'-[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)sulfonyl]carbamimidamido}pentanoic acid
(S,E)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-5-(N'-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)formohydrazonamido)pentanoic acid
Fmoc-N-Me-Arg(Pbf)-OH
N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N2-methyl-L-ornithine | [Molecular Formula]
C35H42N4O7S | [MDL Number]
MFCD02094401 | [MOL File]
913733-27-4.mol | [Molecular Weight]
662.8 |
| Chemical Properties | Back Directory | [Boiling point ]
817.5±75.0 °C(Predicted) | [density ]
1.34±0.1 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Store in freezer, under -20°C | [form ]
powder | [pka]
3.85±0.21(Predicted) |
| Hazard Information | Back Directory | [Chemical Properties]
White powder | [Uses]
Fmoc-N-Me-Arg(pbf)-OH (CAS# 913733-27-4) is a peptide used in the preparation of tetrapeptide aldehyde inhibitors of dengue virus NS3 protease. | [reaction suitability]
reaction type: Fmoc solid-phase peptide synthesis |
|
|